Despite its shortcomings, the fact that the plan is becoming rolled out like a trial is usually a constructive matter, reckons Michel Kazatchkine, a member of the worldwide Commission on Drug Coverage. The strongest method to encourage naysayers is thru giving cold, tricky, irrefutable evidence, he